INTRODUCTION AND OBJECTIVES: Renal transplantation in patients with lower urinary tract (LUT) dysfunction is a unique challenge, as they are at higher risk of urinary tract infection, sepsis, surgical complications, allograft dysfunction and graft loss. We opt to identify the impact of pre-transplant bladder cycling on the urological complications, graft function and lower urinary tract function.
METHODS: The study included patients maintained on hemodialysis for more than 12 months with oliguria or anuria, reduced bladder capacity by ascending cystogram, poor compliance by cystometry, no history of lower urinary tract dysfunction and have no evidence of urological cause of renal failure. Patients were randomly allocated into two groups, group I received direct renal transplantation without bladder recycling. Group II received renal transplant after programmed bladder recycling through bladder instillation of sterile water in amount equal to the estimated bladder capacity to be gradually increased till patient can withstand filling the bladder with 200 cc for 2 hours. Standard renal transplantation was carried out with stented Leich Gregoir ureteroneocystostomy. Urological complications and graft functions were recorded at 3 months. Patients were assessed by IPSS, Cystogram as well as cystometry. To achieve a difference in mean cystometric capacity of 50 cc in favor of bladder training patients, 16 patients in each group are required to achieve a power of 80% and an a error of 0.05.
RESULTS: A total of 22 patients were randomized so far including 11 patients in each group. All the cases underwent right iliac renal allotransplantation. Urinary leakage occurred in 2 cases (18%) in group I that was managed conservatively and subsided with prolongation of the internal stent and one case required percutaneous tube drainage. In group II urinary leakage occurred in one case (9%) that was managed by surgical exploration and redo ureterovesical reimplantation (p¼ 0.07 ). At 3 months, mean serum creatinine was 0.9 mg/dl and 1 mg/dl in both groups respectively (p¼ 0.4 ). Symptom score was 9 and 11 in both groups respectively (p ¼0.09 ). Mean cystometric capacity three months after transplant was 382 cc and 397 cc in both groups respectively (p¼ 0.1).
CONCLUSIONS: Pretransplant programmed bladder recycling for patients with defunctionalized bladder provide no clinical advantage as regard postoperative urological complications, graft function, lower urinary tract symptoms and cystometric capacity. INTRODUCTION AND OBJECTIVES: Percutaneous nephrolithotomy (PCNL) is considered the gold standard minimally invasive treatment for large stone burdens, but post-operative pain control remains challenging. Paravertebral block (PVB) has been described for breast and thoracic surgery as an effective pain control strategy, but is not being utilized for PCNL. The objective of this study was to evaluate the effect of paravertebral block on pain control and opioid use following PCNL.
Source of Funding: none
METHODS: This was a prospective, randomized, double-blind, placebo-controlled study. Willing patients undergoing unilateral PCNL for stone disease were consented and randomized to receive either PVB or placebo intervention in the preoperative area. The PVB consists of a single injection of 20 mL of 0.5% bupivacaine into the T10 paravertebral space under ultrasound guidance. For the placebo intervention, the ultrasound probe is applied, the skin is infiltrated with lidocaine, and pressure is held to mimic injection. The patient, surgeon, and anesthesia team were blinded to the study group. Patients received patient-controlled analgesia (PCA) following surgery. Outcomes were visual analog scale (VAS) pain scores, intra-operative and post-operative opioid use, and anti-emetic use. Statistical analysis was performed using paired t-tests for continuous variables and chi-square tests for categorical variables.
RESULTS: The 45 patients enrolled in the study had no difference in baseline characteristics. There were no complications attributed to the PVB. The average VAS pain score was lower in the PVB group. Intra-operative opioid use, post-operative opioid use, frequency of opioid use, and anti-emetic use were significantly lower in the PVB group as compared to the control group. The time from the conclusion of surgery to the first administration of opioids was longer in the PVB group CONCLUSIONS: To our knowledge, this is the first randomized, double-blind, placebo-controlled trial investigating the use of PVB in PCNL. PVB prior to PCNL improved average VAS pain scores and decreased both intra-operative and post-operative opioid use. The reduction in opioid use likely leads to improved nausea as reflected in decreased anti-emetic use. PVB should be considered an effective strategy to reduce pain for patients undergoing PCNL.
Source of Funding: None

MP75-02 PREDICTORS OF ED VISITS FOLLOWING URETEROSCOPY
Graham Machen*, Lawrence Tsai, Patrick Lowry, Erin Bird, Marawan El Tayeb, Temple, TX INTRODUCTION AND OBJECTIVES: Ureteroscopy is one of the most common ambulatory procedures performed by urologists to manage a variety of different pathologies, including nephrolithiasis and urothelial cancers. As a high volume endourologic center, the vast majority of our emergency department visits occur after ureteroscopy. The affordable care act and centers for Medicare and Medicaid services Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e1003 have recently instituted several quality improvement initiatives, one of which includes decreased hospital reimbursement for re-admissions within 30 days. We attempted to identify trends surrounding outpatient ureteroscopy in hopes of decreasing future ED visits. METHODS: A retrospective chart review from 7/1/2015 to 12/ 31/2015 was performed to identify patients who returned to the ED within 30 days of elective ureteroscopy. CPT codes 52351-6 and 52344-6 were used as search parameters. Patient demographics, operative characteristics, and ED presentation data were collected and analyzed.
RESULTS: A total of 330 ureteroscopies were performed, resulting in 47 ED visits (14.2%) occurring an average of 8.4 days [1e28] postoperatively. 29 were female and 18 male with an average age of 48.2 . 27 (57.4%) were pre-stented an average of 11.5 days preoperatively. All patients were discharged with a stent in place, and 26 (55.3%) with a string attached with instructions to remove at home. 40 (85.1%) were discharged with either Tylenol#3 or Tramadol for pain control. The most common presenting complaint was flank pain (59.6%). Of these patients, 13 (46.4%) presented after the stent was self-pulled, 3 (10.7%) presented after the stent was inadvertently removed, 4 (14.3%) after it was removed via cystoscopy in clinic, and 8 (28.6%) with the stent in place.
CONCLUSIONS: The rate of ED visits following ureteroscopy is estimated to be from 5% to 16%. Our results were in line with previous data demonstrating pain as the most common presenting complaint in the ED following ambulatory surgery. The cause of the pain may be due to issues with self-removal of stents and inadequate postoperative pain management. Some evidence exists that pre-stenting improves stone free rates, which intuitively would lead to decreased ED visits. However, this was not the case in our data as a majority of patients had been prestented. This hypothesis-generating study elicits the need to explore potential methods, including improved pain management and expectations, particularly with self-pulled stents, in order to possibly decrease ED visit rates. INTRODUCTION AND OBJECTIVES: While stone treatment by ureteroscopy is increasingly performed, it incurs frequent unplanned encounters. We aim to identify avoidable predictors to minimize 30-day encounters.
METHODS: We performed retrospective chart review on 157 patients who underwent ureteroscopy for urolithiasis between January and June 2016. Patient demographics, stone characteristics, operative details, and 30-day postoperative unplanned patient-initiated phone calls, emergency department (ED) visits, and readmissions were collected. Administrative patient phone calls were excluded. In order to obtain the most accurate ED and readmission rates, questionnaires were delivered to patients via telephone or email and supplemented chart review data. Fisher 0 s exact and Wilcoxon rank-sum tests were used for qualitative and quantitative variables, respectively.
RESULTS: There were 44 (28%) unplanned patient-initiated phone calls, 23 (14.6%) ED visits, and 8 (5.1%) readmissions postoperatively. The most common chief complaints and ED diagnoses are listed in Table 1 . Factors associated with a higher rate of phone calls include first time stone procedure (37% vs 21%, p ¼ 0.03), outpatient status (30% vs 0%, p ¼ 0.02), intraoperative stent placement (31% vs 0%, p ¼ 0.01), and stent removal at home (59% vs 29%, p ¼ 0.01). Factors associated with increased rate of ED visits were first time stone procedure (23% vs 8%, p ¼ 0.01) and ureteral access sheath usage (30% vs 12%, p ¼ 0.02). Factors associated with a higher rate of readmissions were bilateral procedure (20% vs 3%, p ¼ 0.01) and ureteral access sheath usage (15% vs 3%, p ¼ 0.03). Interestingly, of the 16 patients who had no intraoperative stenting, none had unplanned phone call, ED visit or readmission. Stone number and location, operative time, Charleston comorbidity, and history of preoperative urinary tract infection were not significantly associated with postoperative encounters. CONCLUSIONS: Pain, first time stone treatment, and presence of a ureteral stent were common reasons for postoperative encounters after ureteroscopy. Development of a clinical care pathway for ureteroscopic stone treatment including patient education and pain management may minimize these encounters and improve treatment quality and cost.
Source of Funding: None
MP75-04 VARIATION IN NATIONAL OPIOID PRESCRIBING PATTERNS FOLLOWING OUTPATIENT NEPHROLITHIASIS PROCEDURES
Tudor Borza*, Rodney L. Dunn, Yongmei Qui, Tyler N. Winkelman, Ted A. Skolarus, David C. Miller, Brent K. Hollenbeck, Gregory B. Auffenberg, Ann Arbor, MI INTRODUCTION AND OBJECTIVES: Opioid abuse has become an epidemic in the United States. Surgical episodes account for 40% of all opioids prescribed and thus, surgeons are uniquely positioned to control the supply of available opioids. Given the high incidence of nephrolithiasis, we sought to characterize the variation in opioid prescribing among a national cohort following extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy with lithotripsy (URS).
METHODS: We identified patients who underwent outpatient ESWL and URS between 2012 and 2014 using the de-identified Clinformatics TM Data Mart Database (OptumInsight, Eden Prairie, MN). The database contains administrative health and pharmacy claims from a large, national US health insurer. We limited our cohort to patients that had no concurrent procedures and had not filled an opioid prescription in the 6 months prior to their procedure. We calculated the dose and type of opioids, standardized to morphine milligram equivalents (MME), prescribed within 7 days of the procedure. For urologists with a minimum of 10 cases and 3 opioid prescriptions we quantified the variation in surgeon prescribing patterns.
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